Technical Analysis for AMAR - Amarillo Biosciences

Grade Last Price % Change Price Change
grade B 0.3475 5.30% 0.0175
AMAR closed up 5.3 percent on Thursday, July 18, 2019, on approximately normal volume. The stock rose above its 50 day moving average, improving its intermediate-term outlook by crossing above that important trendline. The stock crossed above its 200 day moving average, improving its long-term outlook by crossing above that critical trendline.

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Weak or Absent Up Up Up
See historical AMAR trend table...

Date Alert Name Type % Chg
Crossed Above 200 DMA Bullish 0.00%
Crossed Above 20 DMA Bullish 0.00%
Crossed Above 50 DMA Bullish 0.00%
Non-ADX 1,2,3,4 Bullish Bullish Swing Setup 0.00%
Bollinger Band Squeeze Range Contraction 0.00%
Outside Day Range Expansion 0.00%
Bollinger Band Squeeze Range Contraction 5.30%
Narrow Range Bar Range Contraction 5.30%
Doji - Bearish? Reversal 5.30%
Bollinger Band Squeeze Range Contraction 5.30%

Older signals for AMAR ...

Get this analysis on your stocks daily!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:
Profile
Amarillo Biosciences, Inc. is engaged in the business of biopharmaceutical research and development. The Company develops biologics for the treatment of human and animal diseases. The Company's focus is research aimed at the treatment of human disease indications, particularly influenza, hepatitis C, thrombocytopenia and other indications using natural human interferon alpha that is administered in a low dose oral form. The Company owns or licenses approximately two issued patents related to the low-dose oral delivery of interferon and it owns an issued patent on its dietary supplement, Maxisal. It has a pending patent, which applies low dose oral interferon to the treatment of Thrombocytopenia.
Medicine RTT Medical Specialties Biopharmaceutical Life Sciences Dietary Supplement Alpha Influenza Healthcare Associated Infections Hepatitis C Specialty Drugs Cytokines Human Disease Antivirals Interferon Thrombocytopenia
Is AMAR a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 3 bullish, 0 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.
Recent News
Indicators
Indicator Value
52 Week High 0.61
52 Week Low 0.122
Average Volume 4,186
200-Day Moving Average 0.3422
50-Day Moving Average 0.34
20-Day Moving Average 0.3401
10-Day Moving Average 0.3301
Average True Range 0.0352
ADX 16.89
+DI 25.9833
-DI 39.1074
Chandelier Exit (Long, 3 ATRs ) 0.2844
Chandelier Exit (Short, 3 ATRs ) 0.3666
Upper Bollinger Band 0.384
Lower Bollinger Band 0.2962
Percent B (%b) 0.58
BandWidth 25.815937
MACD Line -0.0027
MACD Signal Line -0.0025
MACD Histogram -0.0002
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 0.4075
Resistance 3 (R3) 0.4017 0.3758 0.3975
Resistance 2 (R2) 0.3758 0.3606 0.3788 0.3942
Resistance 1 (R1) 0.3617 0.3511 0.3688 0.3675 0.3908
Pivot Point 0.3358 0.3358 0.3394 0.3388 0.3358
Support 1 (S1) 0.3217 0.3206 0.3288 0.3275 0.3042
Support 2 (S2) 0.2958 0.3111 0.2988 0.3008
Support 3 (S3) 0.2817 0.2958 0.2975
Support 4 (S4) 0.2875